Automated solid‐phase synthesis of metabolically stabilized triazolo‐peptidomimetics
Journal of Peptide Science · 2023
DOI: 10.1002/psc.3488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, 2023. Verfasst von Xabier Guarrochena und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Solid-Phase Synthesis Techniques, Peptidomimetics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.
Abstract (Originalsprache)
The use of 1,4‐disubstituted 1,2,3‐triazoles as trans ‐amide bond surrogates has become an important tool for the synthesis of metabolically stabilized peptidomimetics. These heterocyclic bioisosters are generally incorporated into the peptide backbone by applying a diazo‐transfer reaction followed by CuAAC (click chemistry) with an α‐amino alkyne. Even though the manual synthesis of backbone‐modified triazolo‐peptidomimetics has been reported by us and others, no procedure has yet been described for an automated synthesis using peptide synthesizers. In order to efficiently adapt these reactions to an automated setup, different conditions were explored, putting special emphasis on the required long‐term stability of both the diazo‐transfer reagent and the Cu(I) catalyst in solution. ISA·HCl is the reagent of choice to accomplish the diazo‐transfer reaction; however, it was found instable in DMF, the most commonly used solvent for SPPS. Thus, an aqueous solution of ISA·HCl was used to prevent its degradation over time, and the composition in the final diazo‐transfer reaction was adjusted to preserve suitable swelling conditions of the resins applied. The CuAAC reaction was performed without difficulties using [Cu (CH 3 CN) 4 ]PF 6 as a catalyst and TBTA as a stabilizer to prevent oxidation to Cu(II). The optimized automated two‐step procedure was applied to the synthesis of structurally diverse triazolo‐peptidomimetics to demonstrate the versatility of the developed methodology. Under the optimized conditions, five triazolo‐peptidomimetics (8–5 amino acid residues) were synthesized efficiently using two different resins. Analysis of the crude products by HPLC‐MS revealed moderate to good purities of the desired triazolo‐peptidomimetics (70–85%). The synthesis time ranged between 9 and 12.5 h.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
- Vienna Doctoral School in Chemistry, University of Vienna, Vienna, Austria.
- Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Vienna, Austria.
- Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.
- Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Thomas L Mindt
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
Zitieren
APA
Guarrochena, X., Kaudela, B., & Mindt, T. L. (2023). Automated solid‐phase synthesis of metabolically stabilized triazolo‐peptidomimetics. Journal of Peptide Science. https://doi.org/10.1002/psc.3488
Vancouver
Guarrochena X, Kaudela B, Mindt TL. Automated solid‐phase synthesis of metabolically stabilized triazolo‐peptidomimetics. Journal of Peptide Science. 2023. doi:10.1002/psc.3488
BibTeX
@article{Guarrochena2023,
author = {Guarrochena, Xabier and Kaudela, Barbara and Mindt, Thomas L},
title = {Automated solid‐phase synthesis of metabolically stabilized triazolo‐peptidomimetics},
journal = {Journal of Peptide Science},
year = {2023},
doi = {10.1002/psc.3488}
}
EUVIMED